Osteopenia (Disorder) Completed Phase 4 Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopenia (morphologic abnormality) / Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0087613 (Osteopenia (Disorder))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00164008Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss PreventionTreatment